References
Wong AE, Kwaan HC, Grobman WA, Weiss I, Wong CA (2015) Microparticle source and tissue factor expression in pregnancy. Ann Hematol 94:1285–90
Patil R, Ghosh K, Damania K, Bansal V, Satoskar P, Darekar A, Shetty S (2015) Effect of anticoagulant therapy on cell-derived microparticles (MP) and pregnancy outcome in women with pregnancy loss. Br J Haematol. doi: 10.1111/bjh.13460
Patil R, Ghosh K, Satoskar P, Shetty S (2013) Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss. PLoS One 8:e81407
Alijotas-Reig J, Palacio-Garcia C, Farran-Codina I, Zarzoso C, Cabero-Roura L, Vilardell-Tarres M (2011) Circulating cell-derived microparticles in women with pregnancy loss. Am J Reprod Immunol 66:199–208
Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, D’Ercole C, Dignat-George F (2003) Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 89:486–92
Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114:409–414
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
The study was approved by the Institutional Ethics Review Board, i.e., “Institutional Committee for Research on Human Subjects, National Institute of Immunohaematology (ICMR)” and written informed consent was obtained from all participants. All investigations were conducted according to the principles expressed in the Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Patil, R., Ghosh, K. & Shetty, S. Decrease in circulating percentage platelet microparticles during pregnancy—a different perspective. Ann Hematol 95, 533–534 (2016). https://doi.org/10.1007/s00277-015-2554-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-015-2554-1